147 related articles for article (PubMed ID: 7286033)
1. Plasma mexiletine concentrations following combined oral and intramuscular administration.
Bradbrook ID; Feldschreiber P; Morrison PJ; Rogers HJ; Spector RG
Eur J Clin Pharmacol; 1981 Mar; 19(4):301-4. PubMed ID: 7286033
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations and acceptability of mexiletine given by intramuscular injection in patients admitted to a coronary care unit.
Nicholas J; Boyle DM; Kinney CD; Salathia K; Shanks RG
J Cardiovasc Pharmacol; 1986; 8(1):21-8. PubMed ID: 2419687
[TBL] [Abstract][Full Text] [Related]
3. The clinical pharmacology of mexiletine.
Campbell NP; Kelly JG; Adgey AA; Shanks RG
Br J Clin Pharmacol; 1978 Aug; 6(2):103-8. PubMed ID: 678385
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of mexiletine in renal insufficiency.
Baudinet G; Henrard L; Quinaux N; El Allaf D; de Landsheere C; Carlier J; Dresse A
Acta Cardiol Suppl; 1980; (25):55-65. PubMed ID: 6966453
[TBL] [Abstract][Full Text] [Related]
5. Dose independent pharmacokinetics of mexiletine in healthy volunteers.
Pringle T; Fox J; McNeill JA; Kinney CD; Liddle J; Harron DW; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):319-21. PubMed ID: 3964531
[TBL] [Abstract][Full Text] [Related]
6. Adaptation of the dose of mexiletine according to pharmacokinetic data.
Bogaert M
Acta Cardiol Suppl; 1980; (25):67-73. PubMed ID: 6966454
[TBL] [Abstract][Full Text] [Related]
7. Mexiletine in normal volunteers.
Campbell NP; Kelly JG; Adgey AA; Shanks RG
Br J Clin Pharmacol; 1978 Oct; 6(4):372-3. PubMed ID: 698033
[No Abstract] [Full Text] [Related]
8. [Pharmacokinetics of mexiletine and its hydroxymethyl metabolite after intramuscular and intravenous administration of mexiletine in healthy subjects].
Levy-Prades R; Philip F; Danays T; Serradimigni A; Cano JP
Therapie; 1987; 42(1):3-7. PubMed ID: 3590063
[No Abstract] [Full Text] [Related]
9. New electron-capture gas-liquid chromatographic method for the determination of mexiletine plasma levels in man.
Frydman A; Lafarge JP; Vial F; Rulliere R; Alexandre JM
J Chromatogr; 1978 May; 145(3):401-11. PubMed ID: 659526
[TBL] [Abstract][Full Text] [Related]
10. A schedule for combined intravenous and oral dosing with mexiletine.
Holt DW; Hampel G; Volans GN
J Int Med Res; 1979; 7(2):162-4. PubMed ID: 478163
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological properties of mexiletine assessed with respect to plasma concentrations.
Joseph SP; Holt DW
Eur J Cardiol; 1980 Feb; 11(2):115-21. PubMed ID: 7363924
[TBL] [Abstract][Full Text] [Related]
12. Increase of mexiletine plasma levels due to delayed hepatic metabolism in patients with chronic liver disease.
Nitsch J; Steinbeck G; Lüderitz B
Eur Heart J; 1983 Nov; 4(11):810-4. PubMed ID: 6653593
[TBL] [Abstract][Full Text] [Related]
13. The dissolution and oral bioavailability of mexiletine capsules modified for clinical trial. A preliminary report.
Chan K; Tse J; Deeks PA; Pilling M
Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):471-8. PubMed ID: 6668966
[TBL] [Abstract][Full Text] [Related]
14. Absorption and antiarrhythmic efficacy of sustained-release mexiletine.
Holt DW; Chadwick DE; Campbell RW
Clin Ther; 1983; 5(3):268-78. PubMed ID: 6850720
[TBL] [Abstract][Full Text] [Related]
15. [Kinetics and tolerance of a combined intravenous and oral dose of mexiletine during the sub acute phase of myocardial infarction (author's transl)].
Leizorovicz A; Pignat E; Mille A; Boissel JP; Ferry S; Guilluy M; Touboul P
Therapie; 1981; 36(4):413-20. PubMed ID: 7027523
[No Abstract] [Full Text] [Related]
16. Practical considerations in the treatment of ventricular arrhythmias with mexiletine.
Akhtar M
Am Heart J; 1984 May; 107(5 Pt 2):1086-90. PubMed ID: 6372424
[TBL] [Abstract][Full Text] [Related]
17. Mexiletine in the treatment of ventricular arrhythmias.
Henrard L; Carlier J
Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the plasma concentrations and efficacy of mexiletine and of a slow-release preparation of mexiletine in patients admitted to a coronary care unit.
Boyle DM; Barber JM; Chapman C; Khalid I; Kinney CD; McIlmoyle EL; Salathia K; Shanks RG
J Cardiovasc Pharmacol; 1982; 4(2):174-9. PubMed ID: 6175798
[TBL] [Abstract][Full Text] [Related]
19. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.
Chew CY; Collett J; Singh BN
Drugs; 1979 Mar; 17(3):161-81. PubMed ID: 378646
[TBL] [Abstract][Full Text] [Related]
20. Development of a dosage scheme for simultaneous intravenous and oral administration of mexiletine.
Paalman AC; Siebelink J; Roos JC; Dunning AJ
Postgrad Med J; 1977; 53 Suppl 1():128-33. PubMed ID: 876945
[No Abstract] [Full Text] [Related]
[Next] [New Search]
